An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria

Blastocystis spp., the most common protozoan discovered in human feces, has affected about one billion people worldwide so far.Despite significant advancements in the epidemiology and diagnosis of the parasite, no consensus has been reached over the pathogenecity and treatment approach.The most common symptoms related to the protozoan include nausea, vomiting, diarrhea, bloating, weight loss, and intestinal gas.Dermatological symptoms, such as skin rash and urticaria, may coexist with gastrointestinal complaints.Blastocystis spp.has evolved as an emerging parasite around the world in recent times.Research has revealed that the prevalence in urticaria patients was 21.3-61.1%,whereas that in healthy volunteers was 8-29.41%.The studies conducted in Egypt produced the highest prevalence among urticaria patients.The prevalence of Blastocystis spp.varied between 5.69 and 31.9% in urticaria patients and 1.56 and 14.8% in healthy individuals in Trkiye.The most prevalent subtype was subtype 3 worldwide and in Trkiye.Urticaria patients were generally shown to have a higher prevalence of Blastocystis spp.than control groups.Moreover, it was shown that urticarial lesions and urticaria scores improved in patients treated with metronidazole who had Blastocystis spp.Blastocystis spp.could be a part of a healthy microbiota, but there is also research that indicated Blastocystis spp.reduced the amount of beneficial bacteria.Gut microbiota in people with chronic urticaria shows a decrease in the diversity of the gut bacteria besides an increase in organisms that are usually referred to as pathogens, including Proteobacteria, Enterobacterales, Enterobacteriaceae, and Bacilli.Furthermore, by modifying the intestinal microbiota, Blastocystis spp.may indirectly contribute to the etiopathogenesis of urticaria.However, this relationship has not been searched yet, and further investigation is required to assess the correlation between the microbiota and Blastocystis spp. in patients with urticaria.

Authors

Publication Details

Journal
Asthma Allergy Immunology
Published
2025-04-02
DOI
https://doi.org/10.21911/aai.2025.672
Citations
1
Primary Topic
Parasitic Infections and Diagnostics
Type
article
Field-Weighted Citation Impact
2.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria

Gülay Aral Akarsu, Zeynep CELEBI SOZENER, Sevim Bavbek, Özlem Ulusan Bağcı
1 citations
Asthma Allergy Immunology
Parasitic Infections and Diagnostics
2.05
article

An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria

Gülay Aral Akarsu, Zeynep CELEBI SOZENER, Sevim Bavbek, Özlem Ulusan Bağcı
article en
1 citations

Abstract

Blastocystis spp., the most common protozoan discovered in human feces, has affected about one billion people worldwide so far.Despite significant advancements in the epidemiology and diagnosis of the parasite, no consensus has been reached over the pathogenecity and treatment approach.The most common symptoms related to the protozoan include nausea, vomiting, diarrhea, bloating, weight loss, and intestinal gas.Dermatological symptoms, such as skin rash and urticaria, may coexist with gastrointestinal complaints.Blastocystis spp.has evolved as an emerging parasite around the world in recent times.Research has revealed that the prevalence in urticaria patients was 21.3-61.1%,whereas that in healthy volunteers was 8-29.41%.The studies conducted in Egypt produced the highest prevalence among urticaria patients.The prevalence of Blastocystis spp.varied between 5.69 and 31.9% in urticaria patients and 1.56 and 14.8% in healthy individuals in Trkiye.The most prevalent subtype was subtype 3 worldwide and in Trkiye.Urticaria patients were generally shown to have a higher prevalence of Blastocystis spp.than control groups.Moreover, it was shown that urticarial lesions and urticaria scores improved in patients treated with metronidazole who had Blastocystis spp.Blastocystis spp.could be a part of a healthy microbiota, but there is also research that indicated Blastocystis spp.reduced the amount of beneficial bacteria.Gut microbiota in people with chronic urticaria shows a decrease in the diversity of the gut bacteria besides an increase in organisms that are usually referred to as pathogens, including Proteobacteria, Enterobacterales, Enterobacteriaceae, and Bacilli.Furthermore, by modifying the intestinal microbiota, Blastocystis spp.may indirectly contribute to the etiopathogenesis of urticaria.However, this relationship has not been searched yet, and further investigation is required to assess the correlation between the microbiota and Blastocystis spp. in patients with urticaria.

Asthma Allergy Immunology
Openalex Percentile: Top 13%
Parasitic Infections and Diagnostics
2.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

An Overview on Blastocystis spp: The Potential Hidden Cause of Chronic Urticaria — Gülay Aral Akarsu, Zeynep CELEBI SOZENER, et al. · Asthma Allergy Immunology (2025) | TGRS Research Map | TGRS